¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"motor neuron disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • Monge disease
    ¸ùÇ캴
  • mountain disease
    °í»êº´
  • moyamoya disease
    ¸ð¾ß¸ð¾ßº´
  • muscle disease
    ±ÙÀ°º´
  • mycobacterial disease
    Ç×»ê±Õº´, ¹ÌÄÚ¹ÚÅ׸®¾Æº´
  • mycoplasma disease
    ¹ÌÄÚÇö󽺸¶º´
  • maple syrup urine disease
    ´Üdz½Ã·´´¢º´
  • marble bone disease
    ´ë¸®¼®º´, °ñÈ­¼®º´
  • Marburg disease
    ¸¶¸£ºÎ¸£Å©º´
  • Marburg virus disease
    ¸¶¸£ºÎ¸£Å©¹ÙÀÌ·¯½ºº´
  • Marchiafava-Bignami disease
    ¸¶¸£Å°¾ÆÆÄ¹Ù-ºñ³Ä¹Ìº´
  • mast cell disease
    ºñ¸¸¼¼Æ÷º´
  • McArdle¡¯s disease
    ¸Æ¾Æµéº´
  • medullary cystic disease
    ¼ÓÁú³¶º´, ¼öÁú³¶¼ºº´
  • Menetrier disease
    ¸Þ³×Æ®¸®¿¡º´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • mycobacterial disease
    Ç×»ê±Õº´
  • mycoplasma disease
    ¹ÌÄÚÇö󽺸¶º´
  • neoplastic disease
    Á¾¾çº´, ½Å»ý¹°º´
  • nervous disease
    ½Å°æº´
  • neurohypophysial disease
    ½Å°æ³úÇϼöüº´
  • neuromuscular disease
    ½Å°æ±ÙÀ°º´
  • neuronal storage disease
    ½Å°æ¼¼Æ÷ÀúÀ庴
  • neuropathic joint disease
    ½Å°æº´Áõ°üÀýº´
  • notifiable disease
    ½Å°í´ë»óÁúº´
  • nutritional disease
    ¿µ¾çº´
  • nutritional deficiency disease
    ¿µ¾ç°áÇ̺´
  • obliterative arterial disease
    Æó»öµ¿¸Æº´
  • obstructive pulmonary disease
    Æó¼âÆóº´
  • occlusive cerebrovascular disease
    Æó¼â³úÇ÷°üÁúȯ
  • occupational disease
    Á÷¾÷º´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • hemoglobin C disease
    Çì¸ð±Û·Îºó C º´
  • hemoglobin C disease
    Çì¸ð±Û·Îºó C º´
  • hemoglobin D disease
    Çì¸ð±Û·Îºó D º´
  • hemoglobin E disease
    Çì¸ð±Û·Îºó Eº´.
  • hemoglobin E disease
    Çì¸ð±Û·Îºó E º´
  • hemoglobin E disease
    Çì¸ð±Û·Îºó Eº´.
  • hemoglobin H disease
    Çì¸ð±Û·Îºó Hº´.
  • hemoglobin H disease
    Çì¸ð±Û·Îºó H º´
  • hemoglobin H disease
    Çì¸ð±Û·Îºó Hº´.
  • hemoglobin M disease
    Çì¸ð±Û·Îºó M º´
  • hemoglobin M disease
    Çì¸ð±Û·Îºó Mº´.
  • hemoglobin M disease
    Çì¸ð±Û·Îºó Mº´
  • hemoglobin SC disease
    Çì¸ð±Û·Îºó SC º´
  • hemoglobin SD disease
    Çì¸ð±Û·Îºó SDº´.
  • hemoglobin SD disease
    Çì¸ð±Û·Îºó SD º´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • buergers disease
    ¹ö°Å º´ (¡­Ü»)
  • buffalo disease
    ¹°¼Ò³ú¿°(¡­Òàæú).
  • bullous disease
    ¼öÆ÷¼º Áúȯ(â©øÞàõ òðü´)
  • bullous disease
    ¼öÆ÷¼º Áúȯ
  • cadmium workers disease
    Ä«µå¹ÅÁ÷°øº´(ÊṲ̀˭ËÓ).
  • caisson disease
    ÀáÇÔº´(íÖùæÜ»)
  • caisson disease
    ÀáÇÔº´(íÖùÞÜ»), Àá¼öº´(íÖâ©Ü»)
  • caisson disease =decompression sickness
    ÀáÇÔº´(Ëö̰ËÓ)ÊÙ°¨¾Ðº´ÊÙ.
  • calcific mitral disease
    ¼®È¸È­½Â¸ðÆÇ¸·Áúȯ(à´üéûùã¬Ù¶÷ýدòðü´).
  • calcific mitral disease
    ¼®È¸È­½Â¸ðÆÇ¸·Áúȯ(¡­ã¬Ù¶÷ûدòðü´).
  • calomel disease
    °¨È«º´
  • caloric disease
    °í¿Âº´(ÍÔè®Ü»).
  • caloric disease
    °í¿Âº´(Ë­ËíËÓ).
  • canavans disease
    Ä«³ª¹Ý º´ (¡­Ü»)
  • carcinoid heart disease
    Ä«¸£½Ã³ëÀÌµå ½ÉÁúȯ( -ãýòðü´).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
MVA mechanical ventricular assistance; mevalonic acid; mitral valve area; motor vehicle accident
MVC maximum voluntary contraction; motor vehicle crash; mucin; multivane collimator; myocardial vascular...
MVPT Motor-Free Visual Perception Test
NEMD nonspecific esophageal motor dysfunction
PML peripheral motor latency; polymorphonuclear leukocyte; posterior mitral leaflet; progressive multifo...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
ADPKD Autosomal Dominant Polycystic Kidney Disease
ARPKD Autosomal recessive polycystic kidney disease
BKD Bacterial kidney disease
BASDAI Bath Ankylosing Spondylitis Disease Activity Index
BD Beccet disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Paas' disease
    ÆÄ½º º´
  • Paget's disease
    ÆÄ°Ù º´, ÆÄÁ¬ Áúȯ, ÆÄÁ¦Æ®º´, º¯Çü¼º °ñ¿°, ÆäÀÌÁ¬¾¾ º´
    1. Çϳª³ª ȤÀº ¿©·¯ °ñÀÇ ¿°ÁõÀ» µ¿¹ÝÇÏ´Â ¿øÀÎ ºÒ¸íÀÇ Àå¾Ö·Î¼­ ¹«Á¶Á÷¼º °ñ ȸº¹À» µ¿¹ÝÇÏ´Â °ñÀÇ ºñÈÄ¿Í ¿¬È­¸¦ ÀÏÀ¸Å²´Ù. 2. À¯¹æÀÇ Pagetº´Àº ¸¸¼º ½ÀÁø°ú À¯»çÇÏ°í ¾ÆÆ÷Å©¸°¼±ÀÌ ¸¹Àº ºÎÀ§¿¡ »ý±ä´Ù. Ç×¹® ÁÖÀ§¿¡ »ý±â´Â °Íº¸´Ù´Â ¿ÜÀ½ºÎ¿¡ »ý±â´Â °Í¿¡¼­ µ¿¹ÝµÈ ÇѼ± ¾ÏÀÌ ÀÖÀ» È®·üÀÌ ¸¹´Ù. À¯¹æÀÇ Pagetº´Àº ÀÏÃø¼º ¶Ç´Â µå¹°°Ô ¾çÃø¼ºÀ¸·Î ¿À´Â È«¹Ý¼º Àμ³¼º ÆÇÀ¸·Î Áø¹°ÀÌ ³¯ ¼ö ÀÖÀ¸¸ç ¶§¶§·Î À¯¹æ¾ÏÀÌ µ¿¹ÝµÈ´Ù. 3. °ñÀÇ ÀÌÇü¼º ÁúȯÀ¸·Î 40´ë ÈĹÝ, ³²¼º¿¡ ´õ ¸¹À¸³ª, ¿©¼º¿¡¼­ ´õ ½ÉÇÏ´Ù. ´Ù°ñ¼ºÀ¸·Î »êÀçÇÏ¿© Àå°ñ°ú ôÃß¿¡ ½ÉÇÑ º´º¯À» ¾ß±âÇÏ¿© º¯Çü°ú ºÒ±¸°¡ µÈ´Ù. µÎ°³°ñ°ú »ó¾Ç°ñÀÌ °úµµÇÏ°Ô ¼ºÀåÇϸç, ¶§·Î´Â ÇϾǰñÀÇ °úµµ ¼ºÀåµµ ÀϾ´Ù. 4. ÆÄ°ñ ¼¼Æ÷¿Í °ñ¸ð ¼¼Æ÷ Ȱ¼ºÀÌ Á¶È­¸¦ ÀÌ·çÁö ¸øÇϸ鼭 Å©±â´Â Ä¿ÁöÁö¸¸ ´õ ¾àÇÑ °ñÀ» ¸¸µå´Â ³ªÀÌµç ¼ºÀο¡¼­ ¹ß»ýÇÏ´Â ÁúȯÀ¸·Î µ¿ÅëÀÌ ±¤¹üÀ§ÇÏ°Ô ³ªÅ¸³ª¸ç, Ç÷û ¾ËÄ«¸®¼º Àλê È¿¼Ò¿Í ÇÏÀ̵å·Ï½Ã ÇÁ·Ñ¸°ÀÌ Áõ°¡µÇ°í ¾Ç¼º °ñ Á¾¾çÀ¸·Î ¹ßÀüÇÒ °¡´É¼ºÀÌ ³ô´Ù.
  • pandemic disease
    ¹üÀ¯Ç༺ º´
    ±¤¹üÀ§ÇÏ°Ô ÆÛÁ® ¹ß»ýÇÑ À¯Ç༺ Áúȯ.
  • Parkinsonian disease
    ÆÄŲ½¼¾¾ º´
    1. ¹«¿îµ¿Áõ, ÁøÀü, ±Ù °æÁ÷ÀÌ Æ¯Â¡ÀûÀÎ ½Å°æ Àå¾ÖÀÇ 1±º. 2. Á¤ÁöÇϰí ÀÖÀ» ¶§´Â ÁøÀüÀÌ ³ªÅ¸³ªÁö ¾Ê´Â ÁøÀü ¸¶ºñ.
  • pearl disease
    ÁøÁÖº´
    °¡ÃàÀÇ º¹¸· ¹× Àå°£¸· °áÇÙ.
  • pearl-worker's disease
    ÁøÁÖ°ø º´
    °ñ ºñ´ë¸¦ ¼ö¹ÝÇÏ´Â ¹Ýº¹¼º ¿°ÁõÀ¸·Î¼­, ÁøÁÖ ºÐ¸» ¶Ç´Â ¸ÕÁö°¡ ÀÖ´Â Àå¼Ò¿¡¼­ ÀÏÇÏ´Â »ç¶÷µé¿¡°Ô¼­ º¼ ¼ö ÀÖ´Ù.
  • Pellegrini's disease
    Æç·¹±×¸®´Ï º´
    ¹«¸­ÀÇ ³»º¹ÃøºÎ Àδë À§¿¡¼­ ¹Ý¿ù»ó °ñ Çü¼ºÀ» Ư¡À¸·Î ÇÏ´Â ÁúȯÀ¸·Î¼­ ¿Ü»ó¼º Àü½Å Àå¾Ö°¡ ¿øÀÎÀÌ´Ù.
  • pelvic inflammatory disease
    °ñ¹Ý¿° Áúȯ
  • peptic ulcer disease
    ¼ÒÈ­¼º ±Ë¾ç Áúȯ
  • peptic ulcerative disease
    ¼ÒÈ­¼º ±Ë¾ç Áúȯ
    Á¤¼­ÀûÀÎ ½ºÆ®·¹½º, ƯÀÌÇÑ À½½Äµé°ú ´Ù¸¥ Á¾·ùÀÇ Àڱص鿡 ÀÇÇØ °úµµÇÑ À§ »êÀÇ ºÐºñ¿¡ ÀÇÇÑ´Ù°í ¹Ï¾îÁø´Ù. °úµµÇÑ ÃâÇ÷, ºóÇ÷, õ°ø µîÀÇ ÇÕº´ÁõÀÌ ¹ß»ýÇÒ ¼öµµ ÀÖ´Ù.
  • periapical disease
    Ä¡±Ù´Ü ÁÖÀ§ Áúȯ
  • pericardial disease
    ½É³¶ Áúȯ, ½É¸· Áúȯ
  • periodontal disease
    Ä¡ÁÖ Áúȯ
  • peripheral vascular disease
    ¸»ÃÊÇ÷°ü Áúȯ
  • Perrin-Ferraton disease
    Æä·©-Æä¶óÅë º´
    µ¿ÀǾî=sna
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
gaucher's disease, type 1 A progressive genetic disease caused by a defect in an enzyme. The enzyme, called glucocerebrosidase, is needed to break down the chemical glucocerebroside. The enzyme defect in persons with Gaucher's disease (GD) leads to the accumulation of glucocerebroside in the spleen, liver, and lymph nodes. The most common early sign is enlargement of the spleen (located in the upper left abdomen). Other signs include low red blood cell counts (anaemia), a decrease in blood clotting cells (platelets), increased pigmentation of the skin, and a yellow fatty spot on the white of the eye (a pinguecula). Severe bone involvement can lead to pain and collapse of the bone of the hips, shoulders, and spine. The GD gene is on chromosome 1. The disease is a recessive trait. Both parents carry a GD gene and transmit it for their child with the disease. The parents' risk of a child with the disease is 1 in 4 with each pregnancy. This type of Gaucher's disease (noncerebral juvenile Gaucher's disease) is most common in Ashkenazi Jews (of European origin) and is the most common genetic disease among Jews in the United States.
(12 Dec 1998)
Ranikhet disease An influenza-like viral disease of birds, including domestic fowl, characterised by respiratory and gastrointestinal or pneumonic and encephalitic symptoms. First seen near newcastle, england, the infection is also transmissible to humans by contact with infected birds.
(12 Dec 1998)
manic-depressive disease See manic-depression.
(12 Dec 1998)
rat-bite disease A syndrome characterised by recurring fever, rash, and arthralgias occurring days to weeks after a rat bite. The causative agents are either streptobacillus moniliformis or spirillum minus.
(12 Dec 1998)
generalised small bowel disease <radiology> Hypoproteinaemia, sprue, Whipple
(12 Dec 1998)
Raussly disease A rare autosomal dominant neurological disorder with many of the clinical features of hereditary hypertrophic sensorimotor polyneuropathy combined with an essential tremor.
Synonym: hereditary areflexic dystasia.
(05 Mar 2000)
venereal disease <microbiology> A disease contracted through sexual intercourse.
Examples include syphilis, gonorrhoea, chlamydia and lymphogranuloma venereum.
Synonym: sexually transmitted disease.
(12 Jan 1998)
Venereal Disease Research Laboratory <microbiology> A blood test used to diagnose syphilis.
Read as nonreactive or negative if you do not have syphilis. The Venereal Disease Research Laboratory can also be positive is cases of leprosy, malaria, mononucleosis, lupus, hepatitis A and pregnancy.
Positive Venereal Disease Research Laboratory tests are usually followed up by a more specific test (FTA antibodies).
(12 Jan 1998)
Manson's disease Schistosomiasis caused by schistosoma mansoni. It is endemic in africa, the middle east, south america, and the caribbean and affects mainly the bowel, spleen, and liver.
(12 Dec 1998)
Rayer's disease Xanthomatosis with hypercholesterolaemia, resulting from biliary cirrhosis.
Synonym: Rayer's disease.
(05 Mar 2000)
Raynaud's disease <disease> Paroxysmal spasm of the digital arteries causing pallor (blanching) of the fingers and toes.
Maurice Raynaud, French physician (1834-81).
(27 Sep 1997)
veno-occlusive disease <haematology, oncology> A disease that sometimes occurs following high-dose chemotherapy or radiation, in which the blood vessels that carry blood through the liver become swollen and clogged.
Acronym: VOD
(12 Jan 1998)
veno-occlusive disease of the liver Obliterating endophlebitis of small hepatic vein radicles, described in Jamaican children, associated with ingestion of toxic plant substances in bush tea; causes ascites, which may progress to cirrhosis.
(05 Mar 2000)
maple bark disease <radiology> Type of extrinsic allergic alveolitis, source: moldy maple bark in saw mills, organism: Cryptostroma corticale
(12 Dec 1998)
maple syrup urine disease Hereditary disease due to deficiency of an enzyme involved in amino acid metabolism, characterised by urine that smells like maple syrup.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á